Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report
基因组和临床因素对≥18个月龄、组织学预后不良且无MYCN扩增的III期神经母细胞瘤患儿预后的影响:儿童肿瘤协作组(COG)报告
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-3032
Pinto, Navin; Naranjo, Arlene; Ding, Xiangming; Zhang, Fan F; Hibbitts, Emily; Kennedy, Rebekah; Tibbetts, Rachelle; Wong-Michalak, Shannon; Craig, David W; Manojlovic, Zarko; Hogarty, Michael D; Kreissman, Susan; Bagatell, Rochelle; Irwin, Meredith S; Park, Julie R; Asgharzadeh, Shahab